TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy

The development of targeted therapies for both germline and somatic DNA mutations has increased the need for molecular profiling assays to determine the mutational status of specific genes. Moreover, the potential of off-label prescription of targeted therapies favors classifying tumors based on DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Phillip N., Vuong, Huy, Tsai, Pei, Lu, Hsaio-Mei, Mu, Wenbo, Hsuan, Vickie, Hoo, Jayne, Shah, Swati, Uyeda, Lisa, Fox, Susanne, Patel, Harshil, Janicek, Mike, Brown, Sandra, Dobrea, Lavinia, Wagman, Lawrence, Plimack, Elizabeth, Mehra, Ranee, Golemis, Erica A., Bilusic, Marijo, Zibelman, Matthew, Elliott, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356550/
https://www.ncbi.nlm.nih.gov/pubmed/27626691
http://dx.doi.org/10.18632/oncotarget.11910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356550/
https://www.ncbi.nlm.nih.gov/pubmed/27626691
http://dx.doi.org/10.18632/oncotarget.11910

Ejemplares similares